AL
LRCX icon

Aspiriant LLC’s Lam Research LRCX Stock Holding History

Aspiriant LLC’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
3,071
+1,730
+129% +$525K 0.03% 152
2026
Q1 		$287K Sell
1,341
-126
-9% -$28.2K 0.01% 286
2025
Q4 		$251K Buy
+1,467
New +$228K 0.01% 296
2024
Q2 		– Sell
-2,280
Closed -$222K – 313
2024
Q1 		$222K Buy
+2,280
New +$201K 0.01% 297
2023
Q4 		– Sell
-3,810
Closed -$239K – 312
2023
Q3 		$239K Buy
+3,810
New +$250K 0.01% 251

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspiriant LLC's LRCX Position: Q2 2026 in Review

Aspiriant LLC increased its Lam Research (LRCX) stake by 129% in Q2 2026, buying an estimated $525K and bringing the position to 3,071 shares worth $1.33M. The position accounts for 0.03% of the portfolio, ranked #152.

Aspiriant LLC first reported a position in LRCX in Q3 2023 and has held it in 5 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Aspiriant LLC held 3,071 shares of Lam Research worth $1.33M as of Q2 2026.
  • Aspiriant LLC bought 1,730 Lam Research shares in Q2 2026, an estimated $525K.
  • Lam Research made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #152 holding.
  • Aspiriant LLC first reported a position in Lam Research in Q3 2023 and has held it in 5 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.